Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
about
Pleiotropic effects of statinsEffect of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor on disease activity in patients with rheumatoid arthritis: a meta-analysisThe prevention and regression of atherosclerotic plaques: emerging treatments.Assessment of coronary atherosclerosis by IVUS and IVUS-based imaging modalities: progression and regression studies, tissue composition and beyond.Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Reproducibility of intravascular ultrasound iMAP for radiofrequency data analysis: implications for design of longitudinal studies.Rosuvastatin calcium in acute coronary syndromes.Effect of statin therapy on the progression of coronary atherosclerosis.Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound.Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.Rapid changes in plaque composition and morphology after intensive lipid lowering therapy: study with serial coronary CT angiography.High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in JapUnique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?Current Perspectives on rosuvastatin.Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention.Pleiotropic effects of statins. - Basic research and clinical perspectives -.Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.New evidence on pitavastatin: efficacy and safety in clinical studies.Imaging of coronary atherosclerosis: intravascular ultrasound.Drug safety evaluation of rosuvastatin.Statin dose in Asians: is pharmacogenetics relevant?Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.Dyslipidemia: management using optimal lipid-lowering therapy.Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.An update on the benefits and risks of rosuvastatin therapy.The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report.Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque RegressionExploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.Relationship between left coronary artery bifurcation angle and restenosis after stenting of the proximal left anterior descending artery.Xuezhikang reduced arterial stiffness in patients with essential hypertension: a preliminary study.Statins reduce extensive aortic atheromas in patients with abdominal aortic aneurysms.Slightly elevated high-sensitivity C-reactive protein (hsCRP) concentrations are associated with carotid atherosclerosis in women with varying degrees of glucose tolerance.An assessment of risk factors for the complexity of coronary artery disease using the SYNTAX score.Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques.Impact of tissue characteristics on luminal narrowing of mild angiographic coronary stenosis: assessment of integrated backscatter intravascular ultrasound.Advances in Intravascular Imaging: New Insights into the Vulnerable Plaque from Imaging Studies.Rosuvastatin prevents aortic arch plaque progression and improves prognosis in ischemic stroke patients.Rationale and design of the EPISTEME trial: efficacy of post-stroke intensive rosuvastatin treatment for aortogenic embolic stroke.Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultra
P2860
Q26783220-27FD9E8B-ED8C-4CAD-B2EE-9999735677E3Q26851763-FEE1C8B5-B96D-41BC-82B9-74ADCBA9182AQ27691367-3B2D3CA7-3B9D-4A98-A003-1AA596DB5D0CQ30475407-9D38F852-6393-43F4-BB54-A90EA53572CBQ33972551-E179499D-C30D-4C80-BB46-C659DC6AFEE0Q34081201-629100D7-670D-4580-B11B-90B39E334CF4Q34338367-19250856-BD61-4D58-92B7-51485758F61DQ34400201-4FF829A1-C352-4F75-8705-76E2B8AA9DFDQ34500083-0302DE18-6422-4ACE-8848-1CA06451BFD7Q35050945-4515B36F-E137-4802-B95D-D97590F69B09Q36021453-B2B3E6AC-FB77-4EBF-87BA-8A00436660AFQ36239897-3E323C2F-6828-4B4D-90E1-0F22AC2A86A7Q36429790-AE301FDF-9396-4627-B83C-27D6E280EE81Q36796490-07BA478C-BDEA-4FD9-A58B-C1E7A59CC29EQ36836647-E4F7C1DB-2938-4743-B5EB-FAE39AAC1B0CQ37252114-3458D9C8-16C0-41BC-843F-B9CD8D6E6352Q37361667-E68F6FC7-4190-4995-9190-47CAB70E2531Q37433115-2C55466F-2879-4D40-8CC0-F8D9677AFC11Q37702244-1C005495-22B1-406A-B15D-D521CE9C3B67Q37786120-27436109-7AF4-4692-8F34-FF7A32EA2DCAQ37945657-4AD8A056-51CD-4C56-8D65-02B55ABC7AF5Q37951651-528509C8-DC80-44DE-A1E7-6322C343EC0AQ37953462-DCBD9971-64D6-4DAE-A07E-BBA1F9215CCAQ38049066-772D1FC5-7C2C-48D0-92B5-C4B0E8950FB3Q38125941-DC36454E-A21A-40E1-B96F-56B64A6F648FQ38200826-49E2D28C-AC66-4DAE-9D01-9AC873BE30FAQ38478019-52C4BE11-2539-4BA3-A207-C8085844046AQ38504468-DF36A6B2-7CF7-45A3-9A6F-464BE2B1E6A5Q39412607-DC2DF1F5-2C75-46A4-84F7-8C01FF8255CFQ39743831-46DD5E8E-46F9-4A23-B5B9-274AA687CF52Q41586052-7E661091-F97D-40B9-97D7-82DA02BB07B8Q42107637-DD4D4409-93FB-4D77-9E9A-1E0E8B6C2F39Q43023757-5D50476E-B2BC-4C66-AEF6-F239C420A44BQ43983090-A840D2A0-6A76-494D-9C78-0A4CF0CB2D19Q45969236-CC423372-B441-4042-A91C-14B6C1439D77Q46001062-43A515FD-024D-40E2-9E0E-AEDDB72E34A5Q47420265-C7EB3502-EB26-496C-8FA1-3D57F9F08493Q48407138-88F0A8B3-9C7C-4C95-8D72-A78DCAF47B37Q48974343-403F8D61-5D28-4E17-8ADD-E8814E9BF53DQ50225283-CC3CA53C-7620-4853-B236-523EC8520AB7
P2860
Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effect of rosuvastatin on coro ...... in Japanese subjects (COSMOS).
@en
Effect of rosuvastatin on coro ...... ltrasound in Japanese subjects
@nl
type
label
Effect of rosuvastatin on coro ...... in Japanese subjects (COSMOS).
@en
Effect of rosuvastatin on coro ...... ltrasound in Japanese subjects
@nl
prefLabel
Effect of rosuvastatin on coro ...... in Japanese subjects (COSMOS).
@en
Effect of rosuvastatin on coro ...... ltrasound in Japanese subjects
@nl
P2093
P356
P1433
P1476
Effect of rosuvastatin on coro ...... in Japanese subjects (COSMOS).
@en
P2093
Atsushi Hirayama
COSMOS Investigators
Hiroyuki Daida
Masakazu Yamagishi
Masunori Matsuzaki
Satoshi Saito
Tadateru Takayama
Takafumi Hiro
Tetsu Yamaguchi
P304
P356
10.1253/CIRCJ.CJ-09-0358
P577
2009-10-05T00:00:00Z